Analyzing the options chain and the chart patterns of ACVH Achieve Life Sciences prior to the earnings report this week,
I would consider purchasing the 5usd strike price Calls with
an expiration date of 2024-6-21,
for a premium of approximately $0.65.
If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
*new trader*
-ACHV has been trending in a rising open wedge the last 8months
-selling resistance @$5.92, +$.32 from last monthly bottom
-ongoing trials bolster value
ACHV had good earnings in mid-March and has been in an ascending triangle since that time.
The uptrend had a correction April 17th to 20th to which buyers responded with spiking
buying volume. Current volume is 3x relative to the usual and customary historical volume
averages.
I will take a long trade on this when price descends to the support trendline...
ACHC previously ran up in a high tight flag pattern in my previous idea.
It has been slowly ascending in a narrowing channel. ( ascending wedge)
There has been a little push in volume on the indicator as price has
approached the upper boundaries of the channel. The average
directional index has decreased into the " chop zone" where consolidation
and lack...
The problem with candle stick patterns is that it takes time
to master them
--
Also, you need some interest level to really get it
--
Notice this pattern?
There are about 4 indicators on this chart
--
You need to master Japanese candle stick patterns
--
The Top 6 indicators used in this chart:
1-EMA 13 Days
2-Stochastic
3-RSI
4-MACD
5-MACD histogram
6-Japanese...
ACHV on the 4H seems to be demonstrating a "High Bull Flag Pattern"
after a big uptrend to start the year. Earnings on Thursday 3/16 were
quite favorable.On the relative volume indicator Friday, May 17th
showed a paradoxical huge selling volume spike to finish out this week.
( I mislabelled this as upcoming on the chart)
Paradoxically, the last earnings...
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine...
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the global smoking health epidemic...
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the global smoking health epidemic...
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in the United States and internationally.
For this back-testing example, zoom in/out to review the full analysis. Enjoy every sandwich ;) EES
Expecting price action to move to the 72.8% retrace level of the last point on a Bullish Cypher Pattern.
The 72.8% hits directly on the trend line and am expecting a strong upward push - DO YOUR OWN RESEARCH on this pattern!
If you saw my earlier post, as of...
We have a few more days before a breakout.
Some nice upside potential as we are on the last leg up on the cypher pattern.
As price action could change at any time, do your due diligence.
Enjoy every sandwich ;) EES.
ACHV has been trading within a Sideways Channel since Sept. 4th and is currently on the lower end of the channel. The stock has the potential to retest the $10 Levels of Resistance, and if it does, then we're expecting a $11.60-$13.48 wouldn't be impossible to see with this stock. ACHV began it's Late-Stage Trials of Cytisinicline for Smoking Cessation on 10/07/20...
Low float name with a possible uptrend. Looking for a day with high volume (5M plus) for an opportunity. Scoop on dips with a tight leash or short on parabolic move.
Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products includes cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Vancouver,...
